No Data
No Data
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
Spotlight On Nutex Health And 2 Other Leading Growth Stocks With Insider Stake
Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $75
Express News | Nutex Health: Now Beginning to Realize Full Cash Impact of Its Enhanced Arbitration Process That Was Commenced in July 2024
Express News | Nutex Health Issues No Surprises Act (Nsa) Arbitration Update